Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits

Roberto Lorusso1, Samuele Pentiricci, Riccardo Raddino

  • 1Cardiac Surgery Division, Civic Hospital, Brescia, Italy. roberto_lorusso@iol.it

Diabetes
|October 28, 2003
PubMed

Insights

Diabetes impairs saphenous vein grafts used in coronary artery bypass grafting (CABG), affecting vasodilation and structure. Left internal thoracic artery grafts remain unaffected, highlighting the need for better metabolic control in diabetic patients undergoing CABG.

Area of Science:

  • Cardiovascular Surgery
  • Diabetology
  • Vascular Biology

Background:

  • Patients with diabetes undergoing coronary artery bypass grafting (CABG) face a high incidence of cardiac events.
  • The characteristics of CABG conduits are crucial for outcomes but underexplored in diabetic populations.

Purpose of the Study:

  • To investigate the impact of adult-onset diabetes on the vasoreactivity and morphology of venous and arterial grafts used in CABG.
  • To identify predictors of graft degeneration in diabetic patients.

Main Methods:

  • Compared 90 diabetic patients with 70 non-diabetic controls undergoing CABG.
  • Assessed functional (vasoreactivity) and histological (morphological) properties of left internal thoracic artery (LITA) and saphenous vein (SV) grafts.
  • Correlated preoperative metabolic control factors with graft findings.

Main Results:

  • LITA grafts showed preserved function and structure in diabetic patients.
  • SV grafts from diabetic patients exhibited impaired endothelium-dependent vasodilation and significant intimal abnormalities, including atherosclerotic plaques.
  • High proteinuria and glycated hemoglobin (GHb) levels predicted SV graft degeneration.

Conclusions:

  • Arterial grafts (LITA) maintain biological properties in diabetic patients undergoing CABG.
  • Venous grafts (SV) show functional and structural deterioration in diabetic patients, linked to metabolic control.
  • Effective diabetes management is crucial for preserving SV graft integrity post-CABG.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.